Get In Touch
Tmapril cpver 104x80.jpg
Current Issue

animation-neutral-tts-300x100' width='300' height='100' border='0

Contec, Inc., Milliken partner to produce disinfectant

By Niranjan Mudholkar,

Added 18 May 2020

To meet high demand for antibacterial cleaning solutions

Contec, Inc., is scaling up production of its Sporicidin® brand disinfectant, most often used for mold and water damage remediation, and turned to diversified global manufacturer and materials science expert Milliken & Company to help produce mass quantities.

The demand for antibacterial cleaning supplies continues to climb in response to the COVID-19 pandemic, and healthcare institutions are looking for effective alternatives to traditional solutions. To fill this need, Contec, Inc., is scaling up production of its Sporicidin® brand disinfectant, most often used for mold and water damage remediation, and turned to diversified global manufacturer and materials science expert Milliken & Company to help produce mass quantities.

Since 1978, Sporicidin brand disinfectant products have been used for infection and contamination control by hospitals, medical and dental offices, veterinary clinics, and restoration professionals. The EPA-registered intermediate level disinfectant cleans, disinfects and deodorizes, and it provides 100% kill of pathogenic vegetative organisms, including MRSA, VRE and Avian Influenza A Virus (H9N2 and H1N1) with continuous residual activity for up to six months. Compatible with plastics, wood, glass and metals, alcohol-free Sporicidin brand disinfectant is non-staining, non-abrasive and non-corrosive. Notably, the disinfectant carries a Category IV EPA toxicity rating the lowest toxicity rating given to antimicrobials.

"Milliken immediately came to mind when we decided to bring on a new manufacturing partner," shared Jack McBride, Contec, Inc. CEO. "Milliken is a trusted, key community player with the mass production, quality systems and speed-to-market capabilities needed to help us provide critical cleaning solutions to healthcare facilities without delay."

Sporicidin production at Milliken began on Tuesday, May 12, after a record ramp-up of only four weeks. Typical similar partnerships require three to six months to arrange.

"Companies are adapting their core competencies to meet the global challenges brought on by COVID-19," said Halsey M. Cook, president and CEO of Milliken & Company. "Partnering with Contec, Inc. was a natural fit, and gave Milliken the opportunity to quickly reconfigure our manufacturing capabilities and rapidly solve problems for our customers and communities."

END

comments powered by Disqus